Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117389 · ClinicalTrials.gov registry record
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
A clinical trial of Human Papilloma Virus, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 587
- Enrollment target
- 1
- Study location
NCT01117389: Completed study of Human Papilloma Virus, sponsored by St. Jude Children's Research Hospital.
NCT01117389 is a study of Human Papilloma Virus that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 587 participants, below the 8,426-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117389, a study of Human Papilloma Virus, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 587 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will focus on the primary objectives: * To estimate the prevalence of HPV vaccination among a large cohort of childhood cancer survivors and an acquaintance control group. * To describe the difference in HPV vaccination rate and HPV vaccination intent among preadolescent/adolescent females surviving childhood cancer and an acquaintance control group. This study will also focus on the secondary objectives: * To examine sociodemographic, medical, and psychological differences between those who have/have not initiated HPV vaccination and between those who do/do not intend to get vaccinated in the future. * To assess the general predictive influence of sociodemographic, medical, and psychological variables on HPV vaccination and intent among mothers with preadolescent/adolescent daughters.
Conditions Studied
Study Locations (1)
Tennessee
- St . Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 587 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-11 |
What the finished NCT01117389 record still lists
NCT01117389 is an observational study that tracks outcomes without assigning an intervention. The registered 587 participants enrollment target is mid-sized for trials with a published cap, below the 8,426-participant average among 39 other Human Papilloma Virus trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Human Papilloma Virus appearing as the primary indexed condition, and to 0 interventions.
NCT01117389 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01117389 about?
NCT01117389 is a clinical study titled "Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer". This study will focus on the primary objectives: * To estimate the prevalence of HPV vaccination among a large cohort of childhood cancer survivors and an acquaintance control group. * To describe the difference in HPV vaccination rate and HPV vaccination intent among preadolescent/adolescent femal...
What is the current status of trial NCT01117389?
This trial is currently completed. The enrollment target is 587 participants. The study started on 2010-05. Estimated completion is 2012-11.
What conditions does trial NCT01117389 study?
This clinical trial studies the following conditions: Human Papilloma Virus.
Who is sponsoring clinical trial NCT01117389?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01117389 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01117389's enrollment target sits among peer trials
587 15th of 39 higher than 25 of 39 other Human Papilloma Virus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Human Papilloma Virus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921603 · 588 participants · NA
POCUS-Guided Diuresis for Decompensated Heart Failure
- NCT06986954 · 588 participants
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia